NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lumonus

Lumonus

Private
SydneyHealthcare & Life Scienceshttps://www.lumonus.com/

Last Round

Series B

Nov 7, 2025

Total Funding Raised

$19.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Lumonus is a healthcare technology company that provides an AI-powered digital oncology platform to automate and orchestrate critical workflows in radiation oncology.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Workflow Automation, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

radiation oncologytreatment planningclinical workflow automationmedical AIhealthcare SaaSdosimetry automationclinical decision supportAI-native healthcarehealth techmedtechworkflow intelligenceenterprise healthcare softwareclinical optimizationAI-driven oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lumonus Comps

Public and private peers based on sector, stage, and business model.

Lumonus comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lumonus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 7, 2025

Key People

Founding team and executive leadership

Keith Hansen

Chief Executive Officer

Executive Team

Fraser Hughes

Chief Technology Officer

Executive Team

Rebecca Edwards

Chief Financial Officer

Executive Team

Tim Fox

Chief Product Officer

Executive Team

Lumonus Investors

Notable investors and investment history

Lumonus investors
InvestorRounds
Aviron Investment ManagementSeries B
Oncology VenturesSeries B
InvestibleSeries B
Brandon CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    Partnering with Memorial Sloan Kettering Cancer Center to advance radiation oncology.

  • Nov 6, 2025

    $16M round completed.

Lumonus Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lumonus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lumonus's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney
Employee Range64
Year Founded2024
Last FundingNov 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.